Quick Answer
INOVIO PHARMACEUTICALS, INC. reported Total Assets of $74.31 million for fiscal year 2025.
INOVIO PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $74.31M | -34.4% |
| 2024 | $113.20M | -33.8% |
| 2023 | $170.95M | -51.0% |
| 2022 | $348.53M | -29.7% |
| 2021 | $495.94M | -8.1% |
| 2020 | $539.77M | +275.0% |
| 2019 | $143.95M | +9.8% |
| 2018 | $131.11M | -30.0% |
| 2017 | $187.24M | +7.8% |
| 2016 | $173.71M | -18.8% |
| 2015 | $213.84M | +62.3% |
| 2014 | $131.79M | +49.3% |
| 2013 | $88.29M | +95.6% |
| 2012 | $45.14M | -26.1% |
| 2011 | $61.11M | +9.0% |
| 2010 | $56.07M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $69.39M | -35.2% | +1.7% |
| June 30, 2025 | $68.24M | -49.0% | -21.8% |
| March 31, 2025 | $87.27M | -32.4% | -22.9% |
| December 31, 2024 | $113.20M | -33.8% | +5.7% |
| September 30, 2024 | $107.06M | -44.6% | -20.0% |
| June 30, 2024 | $133.80M | -42.6% | +3.6% |
| March 31, 2024 | $129.11M | -51.6% | -24.5% |
| December 31, 2023 | $170.95M | -51.0% | -11.5% |
- INOVIO PHARMACEUTICALS, INC. showed a decrease of -34.4% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, INOVIO PHARMACEUTICALS, INC.’s total assets has grown by 32.5% (from $56.07 million to $74.31 million).
- The most recent figure is from INOVIO PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: